Kadhim Al Banaa, MD
Hematology & Oncology · San Diego, CANPI 1548790041
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Sanofi at 58.3% of the total. 2025 is the largest year on record at $2,431, 4.1 times the $590 reported in 2021. That places this record below the midpoint for hematology & oncology clinicians in CA, where the typical reported total is $3,371.
Across 25 payments — averaging $167.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- E.r. Squibb & Sons, L.L.C.$331
- Amgen$307
- Lilly USA, LLC$245
- Pharmaessentia USA Corporation$141
- Gilead$125
- plus $597 from 9 others
What the payments were for
- Consulting fees$2,30055%
- Food & beverage$1,58938%
- Education$3007%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 3 | $2,444 |
| E.r. Squibb & Sons, L.L.C. | 3 | $331 |
| Amgen | 4 | $307 |
| Lilly USA, LLC | 3 | $245 |
| Pharmaessentia USA Corporation | 2 | $141 |
| Gilead | 1 | $125 |
| Dova Pharmaceuticals | 1 | $110 |
| Sobi, Inc | 1 | $100 |
| Incyte Corporation | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 1 | $99 |
| Genentech, Inc. | 1 | $83 |
| Medexus Pharma, Inc. | 1 | $48 |
| Genentech USA, Inc. | 1 | $22 |
| Exelixis Inc. | 1 | $21 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,190 in reported general payments places this provider in the 50th percentile of 1,363 hematology & oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in San Diego
- Wendy LevinSan Diego$760K
- Rana McKaySan Diego$530K
- Ezra CohenSan Diego$495K
- Annette von DrygalskiSan Diego$406K
- Lyudmila BazhenovaSan Diego$328K
- Sandip PatelSan Diego$295K
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.